Time course of phorbol-12-myristate-13-acetate (PMA)-induced down-regulation of topoisomerase II in human leukemia cells

Amy L. Ellis, Leonard A. Zwelling

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The time course of the down-regulation of topoisomerase II associated with phorbol-induced differentiation was quantified in two human HL-60 leukemia cell lines. In the line sensitive to phorbol-induced differentiation (S cells), immunoreactive topoisomerase II levels did not begin to fall until 12 hr following exposure of the cells to phorbol ester. Thereafter, levels declined over the next 36 hr. By contrast, phorbol treatment of the phorbol ester tolerant cell line (PET cells) produced a transient decrease in topoisomerase II only to be followed by a recovery to pretreatment levels. The patterns of the alterations in topoisomerase II mRNA levels mirrored those of the alterations in immunoreactive topoisomerase II. Unexpectedly, nuclear run-on studies revealed that transcriptional start sites were not reduced in either cell line following their exposure to phorbol esters. These data suggest that the down-regulation of topoisomerase II is a consequence rather than a cause of phorbol-induced differentiation in HL-60 cells. Furthermore, this down-regulation is not mediated by a decrease in the number of topoisomerase II transcription sites.

Original languageEnglish (US)
Pages (from-to)1842-1845
Number of pages4
JournalBiochemical Pharmacology
Volume48
Issue number9
DOIs
StatePublished - Nov 1 1994

Fingerprint

Type II DNA Topoisomerase
Leukemia
Acetates
Down-Regulation
Phorbol Esters
HL-60 Cells
Cells
Cell Line
Transcription
phorbol-12-myristate
Cell Differentiation
Recovery
Messenger RNA
phorbol

Keywords

  • differentiation
  • leukemia
  • phorbol resistance
  • topoisomerase II

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Cite this

Time course of phorbol-12-myristate-13-acetate (PMA)-induced down-regulation of topoisomerase II in human leukemia cells. / Ellis, Amy L.; Zwelling, Leonard A.

In: Biochemical Pharmacology, Vol. 48, No. 9, 01.11.1994, p. 1842-1845.

Research output: Contribution to journalArticle

@article{6074e17aef86442b8f4c618549692162,
title = "Time course of phorbol-12-myristate-13-acetate (PMA)-induced down-regulation of topoisomerase II in human leukemia cells",
abstract = "The time course of the down-regulation of topoisomerase II associated with phorbol-induced differentiation was quantified in two human HL-60 leukemia cell lines. In the line sensitive to phorbol-induced differentiation (S cells), immunoreactive topoisomerase II levels did not begin to fall until 12 hr following exposure of the cells to phorbol ester. Thereafter, levels declined over the next 36 hr. By contrast, phorbol treatment of the phorbol ester tolerant cell line (PET cells) produced a transient decrease in topoisomerase II only to be followed by a recovery to pretreatment levels. The patterns of the alterations in topoisomerase II mRNA levels mirrored those of the alterations in immunoreactive topoisomerase II. Unexpectedly, nuclear run-on studies revealed that transcriptional start sites were not reduced in either cell line following their exposure to phorbol esters. These data suggest that the down-regulation of topoisomerase II is a consequence rather than a cause of phorbol-induced differentiation in HL-60 cells. Furthermore, this down-regulation is not mediated by a decrease in the number of topoisomerase II transcription sites.",
keywords = "differentiation, leukemia, phorbol resistance, topoisomerase II",
author = "Ellis, {Amy L.} and Zwelling, {Leonard A.}",
year = "1994",
month = "11",
day = "1",
doi = "10.1016/0006-2952(94)90472-3",
language = "English (US)",
volume = "48",
pages = "1842--1845",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Time course of phorbol-12-myristate-13-acetate (PMA)-induced down-regulation of topoisomerase II in human leukemia cells

AU - Ellis, Amy L.

AU - Zwelling, Leonard A.

PY - 1994/11/1

Y1 - 1994/11/1

N2 - The time course of the down-regulation of topoisomerase II associated with phorbol-induced differentiation was quantified in two human HL-60 leukemia cell lines. In the line sensitive to phorbol-induced differentiation (S cells), immunoreactive topoisomerase II levels did not begin to fall until 12 hr following exposure of the cells to phorbol ester. Thereafter, levels declined over the next 36 hr. By contrast, phorbol treatment of the phorbol ester tolerant cell line (PET cells) produced a transient decrease in topoisomerase II only to be followed by a recovery to pretreatment levels. The patterns of the alterations in topoisomerase II mRNA levels mirrored those of the alterations in immunoreactive topoisomerase II. Unexpectedly, nuclear run-on studies revealed that transcriptional start sites were not reduced in either cell line following their exposure to phorbol esters. These data suggest that the down-regulation of topoisomerase II is a consequence rather than a cause of phorbol-induced differentiation in HL-60 cells. Furthermore, this down-regulation is not mediated by a decrease in the number of topoisomerase II transcription sites.

AB - The time course of the down-regulation of topoisomerase II associated with phorbol-induced differentiation was quantified in two human HL-60 leukemia cell lines. In the line sensitive to phorbol-induced differentiation (S cells), immunoreactive topoisomerase II levels did not begin to fall until 12 hr following exposure of the cells to phorbol ester. Thereafter, levels declined over the next 36 hr. By contrast, phorbol treatment of the phorbol ester tolerant cell line (PET cells) produced a transient decrease in topoisomerase II only to be followed by a recovery to pretreatment levels. The patterns of the alterations in topoisomerase II mRNA levels mirrored those of the alterations in immunoreactive topoisomerase II. Unexpectedly, nuclear run-on studies revealed that transcriptional start sites were not reduced in either cell line following their exposure to phorbol esters. These data suggest that the down-regulation of topoisomerase II is a consequence rather than a cause of phorbol-induced differentiation in HL-60 cells. Furthermore, this down-regulation is not mediated by a decrease in the number of topoisomerase II transcription sites.

KW - differentiation

KW - leukemia

KW - phorbol resistance

KW - topoisomerase II

UR - http://www.scopus.com/inward/record.url?scp=0028033035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028033035&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(94)90472-3

DO - 10.1016/0006-2952(94)90472-3

M3 - Article

C2 - 7980655

AN - SCOPUS:0028033035

VL - 48

SP - 1842

EP - 1845

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 9

ER -